Literature DB >> 23371483

1,25-Dihydroxyvitamin D3 -induced intestinal calcium transport is impaired in β-globin knockout thalassemic mice.

Narattaphol Charoenphandhu1, Kamonshanok Kraidith, Jarinthorn Teerapornpuntakit, Kanogwun Thongchote, Pissared Khuituan, Saovaros Svasti, Nateetip Krishnamra.   

Abstract

Besides being a common haematological disorder caused by a reduction in β-globin production, β-thalassemia has been reported to impair body calcium homeostasis, leading to massive bone loss and increased fracture risk. Here, we demonstrated that heterozygous β-globin knockout thalassemic mice had a lower rate of duodenal calcium absorption compared with the wild-type littermates, whereas the epithelial electrical parameters, including transepithelial resistance, were not affected, suggesting no change in the epithelial integrity and permeability. Daily subcutaneous injection of 1 µg kg(-1) 1,25-dihydroxyvitamin D3 [1,25(OH)2 D3 ] for 3 days enhanced the duodenal calcium absorption in wild-type, but not in thalassemic mice. Although β-thalassemia increased the mRNA level of divalent metal transporter-1, an iron transporter in the duodenum, it had no effect on the transcripts of ferroportin-1 or the principal calcium transporters. In conclusion, β-thalassemia impaired the 1,25(OH)2 D3 -dependent intestinal calcium absorption at the post-transcriptional level, which, in turn, contributed to the dysregulation of body calcium metabolism and β-thalassemia-induced osteopenia.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Ussing chamber; divalent metal transporter (DMT)-1; duodenum; thalassemia; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 23371483     DOI: 10.1002/cbf.2956

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  6 in total

1.  Na+/H+ exchanger 3 inhibitor diminishes hepcidin-enhanced duodenal calcium transport in hemizygous β-globin knockout thalassemic mice.

Authors:  Narattaphol Charoenphandhu; Kamonshanok Kraidith; Kornkamon Lertsuwan; Chanakarn Sripong; Panan Suntornsaratoon; Saovaros Svasti; Nateetip Krishnamra; Kannikar Wongdee
Journal:  Mol Cell Biochem       Date:  2016-12-19       Impact factor: 3.396

Review 2.  Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.

Authors:  Kornkamon Lertsuwan; Kannikar Wongdee; Jarinthorn Teerapornpuntakit; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2018-02-26       Impact factor: 2.781

3.  Mild-intensity physical activity prevents cardiac and osseous iron deposition without affecting bone mechanical property or porosity in thalassemic mice.

Authors:  Narattaphol Charoenphandhu; Supagarn Sooksawanwit; Ratchaneevan Aeimlapa; Natchayaporn Thonapan; Pornpailin Upanan; Punyanuch Adulyaritthikul; Saowalak Krungchanuchat; Nattapon Panupinthu; Jarinthorn Teerapornpuntakit; Catleya Rojviriya; Kornkamon Lertsuwan; Saovaros Svasti; Kannikar Wongdee
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

4.  Fe3+ opposes the 1,25(OH)2D3-induced calcium transport across intestinal epithelium-like Caco-2 monolayer in the presence or absence of ascorbic acid.

Authors:  Sukpapohn Phummisutthigoon; Kornkamon Lertsuwan; Nattapon Panupinthu; Ratchaneevan Aeimlapa; Jarinthorn Teerapornpuntakit; Wasutorn Chankamngoen; Jirawan Thongbunchoo; Narattaphol Charoenphandhu; Kannikar Wongdee
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

5.  Responses of primary osteoblasts and osteoclasts from hemizygous β-globin knockout thalassemic mice with elevated plasma glucose to 1,25-dihydroxyvitamin D3.

Authors:  Narattaphol Charoenphandhu; Ratchaneevan Aeimlapa; Supagarn Sooksawanwit; Jirawan Thongbunchoo; Jarinthorn Teerapornpuntakit; Saovaros Svasti; Kannikar Wongdee
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

6.  Association of vitamin D and FGF23 with serum ferritin in hypoparathyroid thalassemia: a case control study.

Authors:  Forough Saki; Azita Salehifar; Seyed Reza Kassaee; Gholamhossein Ranjbar Omrani
Journal:  BMC Nephrol       Date:  2020-11-16       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.